Mary Jane Raymond
Analyst · Needham & Company. Your line is now open
Thank you, Chuck and Fran. For FY15 our revenue growth of 9% was 2% organic. Laser solutions 13% growth was 9% organic baring in mind it was this segments growth that was also the most affected by currency. Photonics 20% growth was 6% organic and there were no acquisition effects this year in performance product. As a second point on the revenue, our Q4 revenue of $197 million was over the top end of our guidance of $185 million to $193 million due to some of our customers requiring shipments in the fourth quarter that we would expect it to be in Q1 FY16. We did very well on our margin targets this year even though we were a little shy on the adjusted EBITDA margins due to currency effects and an intangible asset write-off of $2 million. Growth margin of 36.6% compared to 33.2% for FY14. The operating margin of 10.4% compared to 6.8% last year and the adjusted EBITDA margin without the settlement benefit was 17.3% compared to 15.1% in FY14. The operating and adjusted EBITDA margins are all inclusive of currency and restricting effects. They exclude the indemnification settlement in our favor of $7.6 million from the FY14 acquisitions. Our fourth quarter book-to-bill ratio of 1.0 caps a good year of improved bookings. Full year, the book to bill ratio was 1.03. Our backlog of $242 million consists of $73 million in laser solutions, $68 million in photonics, and $101 million in performance products. The currency effect on our revenue was $12 million or about 2% reduction in our annual growth rate. The euro and yen falling over 20% from June of 2014 coupled with the growth in our businesses at HIGHYAG in Berlin and Laser Enterprise in Zurich with their euro-based revenues really changed the currency profile of our company, but the end of the day, which is less than 0.5% effect on the operating margin. The restructuring cost recorded in this quarter are $2.6 million, including the settling of a lease in Australia. This is $1.5 million for Photonics and $1.1 million for Performance Products. Full year, the pretax charge was $6.4 million, $4.5 million in Photonics and $1.9 million in Performance Products. The adjusted EBITDA of $0.94 a share for this year, reported EPS of $1.05 per share compares to a reported $0.60 per share last year. We worked hard for this improvement and believe the improvements that we have made will serve us very well going into the FY2016 year. Turning to our cash and capital expenditures, our cash flow from operations was $1.29 million compared to $95 million for fiscal year 2014. We paid down $66 million of our debt this year bringing our debt level to $176 million. With $174 million cash on hand, we should be in the net cash position by the end of the first quarter of this year. We did not repurchase any stock this quarter, but we have repurchased $13 million in fiscal year 2015. We reduced our share count by $1.1 million shares. Our total share count is 62,586,000 compared to 63,686,000 for fiscal year 2014. We invested $52 million in capital this year, including $13 million for the purchase of the Highyag building in Germany during the first quarter. We expect the FY2016 capital investments to be similar to this year or between $50 million and $55 million. Our equity based compensation for the year was $11.4 million and for fiscal year 2016, we expect equity based compensation to range from $12 million to $14 million. Our year-to-date tax effect was 17%, very close to our range of 14% to 16%. This rate compares to last year’s rate of 16%, which also benefitted from the R&D tax credit. For fiscal year 2016, we expect the tax rate to range from 21 to 23 on the theory, but the R&D tax credit is not removed. Turning to our outlook for the first quarter of FY2016. For the first fiscal quarter ended September 30, 2015, which is our seasonally low quarter, the company currently forecast revenues to range from $180 million to $190 million and earnings per share to range from $0.20 to $0.25 per share diluted. We expect the second half of the year to follow our usual pattern of being stronger than the first half. Comparable results for the quarter ended September 30, 2014, were revenues of $185.8 million and earnings per share of $0.20 per share diluted. This is all at prevailing exchange rates. Before we turn over to questions, our first quarter earnings release date is slated for Tuesday, October 27, 2015. This concludes our prepared remarks. As we turn to Q&A, I will remind you that our answers to your questions may contain forward-looking statements, which are based on our knowledge today and for which actual results may differ materially. Kayley, you may open the line for questions.